Healthcare -
Biotechnology - NASDAQ - US
$ 7.92
-18.9 %
$ 397 M
Market Cap
-1.73
P/E
RGNX - REVENUE
Revenue RGNX - REGENXBIO Inc.
83.3 M
LAST VALUE
-14.02%
2 YEAR CAGR
18.79%
5 YEAR CAGR
29.84%
10 YEAR CAGR